News

First blood test for Alzheimer’s diagnosis cleared by FDA
The FDA has cleared the first-ever blood test for early Alzheimer's detection, which the agency says reduces the need for ...
FDA endorses first-of-its-kind blood test for Alzheimer’s disease
The Food and Drug Administration cleared a new kind of test for Alzheimer’s disease designed to be more accessible and less ...
FDA greenlights first blood test to help diagnose Alzheimer’s disease in the US
The US Food and Drug Administration has given marketing clearance to a blood test to help diagnose Alzheimer’s disease, ...
US FDA approves world’s first blood test for Alzheimer’s, and what it means
The FDA has approved the Lumipulse Plasma Ratio test, a groundbreaking blood test for early dementia detection. This less ...
FDA clears first blood test to detect Alzheimer's disease. What to know about Lumipulse.
The Lumipulse Alzheimer's blood test is the first of a new generation of tests that may replace brain scans and spinal taps to detect the disease.
FDA greenlights marketing of first Alzheimer's blood test for some patients
Japan-based Fujirebio's test, which helps doctors diagnose Alzheimer's disease, is intended for patients with signs of ...
FDA clears first blood test to reliably predict Alzheimer’s disease
The Food and Drug Administration (FDA) announced Friday it had cleared a new test to help diagnose adults with Alzheimer’s ...
Fierce Biotech1d
FDA clears its first blood test for diagnosing Alzheimer's disease, with Fujirebio's Lumipulse
The FDA said it has issued its first official green light for a blood test to help diagnose Alzheimer’s disease, adding that ...
New blood test for Alzheimer's approved by FDA
The U.S. Food and Drug Administration on Friday approved a new blood test for the early detection of Alzheimer's disease in ...
Statement from the Alzheimer's Drug Discovery Foundation (ADDF) on FDA Approval of the First Blood Test to Aid in Alzheimer's Diagnosis
Today, the FDA's approved the Lumipulse G pTau217/β-Amyloid 1-42 Plasma Ratio, marking a pivotal moment in the fight against ...
FDA greenlights first blood test to diagnose Alzheimer's disease
The Food and Drug Administration (FDA) has cleared Lumipulse G for U.S. commercialization as the first blood-based test that ...
Medscape1d
FDA Clears First Diagnostic Blood Test for Alzheimer's Disease
The Lumipulse G pTau217/Beta-Amyloid 1-42 Plasma Ratio is for the early detection of amyloid plaques associated with Alzheimer’s disease in symptomatic adults 55 years and older.